Hormonal Therapy Resistance and Breast Cancer: Involvement of Adipocytes and Leptin

被引:21
|
作者
Delort, Laetitia [1 ]
Bougaret, Lauriane [1 ]
Cholet, Juliette [1 ]
Vermerie, Marion [1 ]
Billard, Hermine [1 ]
Decombat, Caroline [1 ]
Bourgne, Celine [2 ]
Berger, Marc [2 ]
Dumontet, Charles [3 ]
Caldefie-Chezet, Florence [1 ]
机构
[1] Univ Clermont Auvergne, CRNH Auvergne, INRA, UNH, F-63000 Clermont Ferrand, France
[2] CHU Estaing, Serv Hematol Biol, F-63000 Clermont Ferrand, France
[3] Univ Lyon 1, INSERM U1052, CNRS 5286, Canc Res Ctr Lyon, F-69008 Lyon, France
关键词
breast cancer; adipose secretome; leptin; hormonal therapy resistance; cancer stem cells; ADIPOSE-TISSUE; ENDOCRINE THERAPY; STEM-CELLS; IDENTIFICATION; INTERLEUKIN-6; OBESITY; STAT3;
D O I
10.3390/nu11122839
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Obesity, a recognized risk factor for breast cancer in postmenopausal women, is associated with higher mortality rates regardless of menopausal status, which could in part be explained by therapeutic escape. Indeed, adipose microenvironment has been described to influence the efficiency of chemo- and hormonal therapies. Residual cancer stem cells could also have a key role in this process. To understand the mechanisms involved in the reduced efficacy of hormonal therapy on breast cancer cells in the presence of adipose secretome, human adipose stem cells (hMAD cell line) differentiated into mature adipocytes were co-cultured with mammary breast cancer cells and treated with hormonal therapies (tamoxifen, fulvestrant). Proliferation and apoptosis were measured (fluorescence test, impedancemetry, cytometry) and the gene expression profile was evaluated. Cancer stem cells were isolated from mammospheres made from MCF-7. The impact of chemo- and hormonal therapies and leptin was evaluated in this population. hMAD-differentiated mature adipocytes and their secretions were able to increase mammary cancer cell proliferation and to suppress the antiproliferative effect of tamoxifen, confirming previous data and validating our model. Apoptosis and cell cycle did not seem to be involved in this process. The evaluation of gene expression profiles suggested that STAT3 could be a possible target. On the contrary, leptin did not seem to be involved. The study of isolated cancer stem cells revealed that their proliferation was stimulated in the presence of anticancer therapies (tamoxifen, fulvestrant, doxorubicine) and leptin. Our study confirmed the role of adipocytes and their secretome, but above all, the role of communication between adipose and cancer cells in interfering with the efficiency of hormonal therapy. Among the pathophysiological mechanisms involved, leptin does not seem to interfere with the estrogenic pathway but seems to promote the proliferation of cancer stem cells.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] SERUM LEPTIN LEVEL IN BREAST CANCER
    Koprivcic, Ivan
    Marjanovic, Ksenija
    Matic, Anita
    Levak, Maja Tolusic
    Lovric, Ivan
    Pauzar, Biljana
    Eric, Ivan
    Wertheimer, Vjekoslav
    ACTA CLINICA CROATICA, 2022, 61 (01) : 79 - 85
  • [22] Insight on the Role of Leptin: A Bridge from Obesity to Breast Cancer
    Buonaiuto, Roberto
    Napolitano, Fabiana
    Parola, Sara
    De Placido, Pietro
    Forestieri, Valeria
    Pecoraro, Giovanna
    Servetto, Alberto
    Formisano, Luigi
    Formisano, Pietro
    Giuliano, Mario
    Arpino, Grazia
    De Placido, Sabino
    De Angelis, Carmine
    BIOMOLECULES, 2022, 12 (10)
  • [23] Resistance to endocrine therapy in breast cancer
    Kurebayashi, J
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (Suppl 1) : S39 - S46
  • [24] Resistance to endocrine therapy in breast cancer
    Junichi Kurebayashi
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 39 - 46
  • [25] Mechanisms of resistance to hormonal treatment in breast cancer
    Pilar Eroles
    Ana Bosch
    Begoña Bermejo
    Ana Lluch
    Clinical and Translational Oncology, 2010, 12 : 246 - 252
  • [26] Mechanisms of resistance to hormonal treatment in breast cancer
    Eroles, Pilar
    Bosch, Ana
    Bermejo, Begona
    Lluch, Ana
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2010, 12 (04): : 246 - 252
  • [27] Adipocytes secretome from normal and tumor breast favor breast cancer invasion by metabolic reprogramming
    Zaoui, Maurice
    Morel, Mehdi
    Louadj, Lila
    Ferrand, Nathalie
    Lamaziere, Antonin
    Uzan, Catherine
    Canlorbe, Geoffroy
    Atlan, Michael
    Sabbah, Michele
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (05): : 1389 - 1401
  • [28] Leptin and leptin receptor expression as biomarkers for breast cancer: a retrospective study
    Wang, Yan
    Du, Lili
    Jing, Jiexian
    Zhao, Xianwen
    Wang, Xing
    Hou, Shenghuai
    BMC CANCER, 2023, 23 (01)
  • [29] Evidence of an Autocrine Role for Leptin and Leptin Receptor in Human Breast Cancer
    Wazir, Umar
    Al Sarakbi, Wael
    Jiang, Wen G.
    Mokbel, Kefah
    CANCER GENOMICS & PROTEOMICS, 2012, 9 (06) : 383 - 387
  • [30] The Leptin Axis and Its Association With the Adaptive Immune System in Breast Cancer
    Garcia-Estevez, Laura
    Gonzalez-Martinez, Silvia
    Moreno-Bueno, Gema
    FRONTIERS IN IMMUNOLOGY, 2021, 12